| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $796.9M | +5.0% |
| Cost of Revenue | $83.3M | -4.3% |
| Gross Profit | $713.6M | +6.2% |
| R&D Expense | $108.6M | +8.4% |
| SG&A Expense | $125.8M | +1.7% |
| Operating Income | $208.4M | +38.6% |
| Pre-tax Income | $103.8M | +204.1% |
| Income Tax | -$8.1M | -118.7% |
| Net Income | $111.9M | +1328.5% |
| EPS (Basic) | $0.66 | +1200.0% |
| EPS (Diluted) | $0.64 | +1166.7% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $251.8M | -11.5% |
| Short-term Investments | $7.5M | +66.9% |
| Accounts Receivable | $113.4M | +9.6% |
| Current Assets | $403.5M | -4.2% |
| Total Assets | $3.17B | -2.5% |
| Current Liabilities | $475.3M | +1.4% |
| Long-term Debt | $1.21B | +0.3% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $188.3M | +2.6% |
| Capital Expenditures | $5.6M | +28.9% |
| Investing Cash Flow | -$23.1M | -619.3% |
| Financing Cash Flow | -$197.0M | -699.3% |
| Free Cash Flow | $182.7M | +2.0% |
| Total Liabilities |
| $1.77B |
| -2.3% |
| Stockholders' Equity | $1.40B | -2.9% |